Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Pharmaceuticals & Medical Devices Bureau Of India has floated a tender for Ambroxol Hydrochloride 15 mg, Guaifenesin 50 mg and Levosalbutamol Sulphate 1 mg Syrup. The project location is New Delhi, Delhi (NCT), India. The reference number is PMBI/DRUG/RC-217/2024 and it is closing on 30 Jul 2024. Suppliers can request Register free of cost to get the complete Tender details and download the document.
Procurement Summary
State : Delhi (NCT)
Summary : Ambroxol Hydrochloride 15 mg, Guaifenesin 50 mg and Levosalbutamol Sulphate 1 mg Syrup
Deadline : 30 Jul 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 104189969
Document Ref. No. : PMBI/DRUG/RC-217/2024
Competition : NCB
Financier : Self Financed
Purchaser Ownership : Public
Document Fees : Refer Document
Tender Value : Refer Document
EMD : ₹ 1000000.00
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Tenders are invited for Ambroxol Hydrochloride 15 mg, Guaifenesin 50 mg and Levosalbutamol Sulphate 1 mg Syrup
Documents
Sign in with Google